Synthesis and in vitro and in vivo activity of analogs of growth hormone‐releasing hormone (GH‐RH) with C‐terminal agmatine

MARTA ZARANDI, VALER CSERNUS, LAZARO BOKSER, SANDOR BAJUSZ, KATE GROOT, ANDREW V. SCHALLY

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

In the search for more active analogs of human growth hormone-releasing hormone (GH-RH), 37 new compounds were synthesized by solid phase methodology, purified, and tested biologically. Most of the analogs contained a sequence of 27 amino acids and N-terminal desaminotyrosine (Dat) and C-terminal agmatine (Agm), which are not amino acids. In addition to Dat in position 1 and Agm in position 29, the majority of the analogs had Ala15 and Nle27 substitutions and one or more additional L- or D-amino acid modifications. [Dat1, Ala15, Nle27]GH-RH(1-28)Agm (MZ-2-51) was the most active analog. Its in vitro GH-releasing potency was 10.5 times higher than that of GH-RH(1-29)NH2 and in the i.v. in vivo assay, MZ-2-51 was 4-5 times more active than the standard. After s.c. administration to rats, MZ-2-51 showed an activity 34 times higher at 15 min and 179 times greater at 30 min than GH-RH(1-29)NH2 and also displayed a prolonged activity. D-Tyr10, D-Lys12, and D-Lys21 homologs of MZ-2-51 also showed enhanced activities. Thus, [Dat1, D-Tyr10, Ala15, Nle27]GH-RH(1-28)Agm (MZ-2-159), [Dat1, D-Lys12, Ala15, Nle27]GH-RH(1-28)AGM (MZ-2-57), and [Dat1, Ala15, D-Lys21, Nle27]GH-RH(1-28)Agm (MZ-2-75) were 4-6 times more active in vitro than GH-RH(1-29)NH2. In vivo, after i.v. administration, analog MZ-2-75 was equipotent and analogs MZ-2-159 and MZ-2-57 about twice as potent as the standard. After s.c. administration, the potencies of MZ-2-57 and MZ-2-75 were 10-14 times higher than the standard at 15 min and 45-89 times greater when determined at 30 min. Most of the analogs containing two or more D-amino acid substitutions were less active than GH-RH(1-29)NH2 or inactive. Our studies indicate that very potent GH-RH analogs can result from the combination of agmatine in position 29 with other substitutions.

Original languageEnglish (US)
Pages (from-to)499-505
Number of pages7
JournalInternational journal of peptide and protein research
Volume36
Issue number6
DOIs
StatePublished - Dec 1990
Externally publishedYes

Keywords

  • GH-RH analogs
  • human growth hormone-releasing hormone

ASJC Scopus subject areas

  • Biochemistry

Fingerprint Dive into the research topics of 'Synthesis and in vitro and in vivo activity of analogs of growth hormone‐releasing hormone (GH‐RH) with C‐terminal agmatine'. Together they form a unique fingerprint.

  • Cite this